Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famitinib vs placebo in advanced colorectal adenocarcinoma
CTR20150185Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of famitinib in colorectal adenocarcinoma, sponsored by Hengrui Therapeutics. Started Apr 2015; status: completed.
02
Drugs
famitinib
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on CTR20150185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150185.